Small Cap📈 ASX: SLD
Saluda Medical, Inc. (ASX: SLD)
Published 28 September 2026Penny Stock Spotlight Report
Saluda Medical, Inc.ASX: SLDSaluda Medical, Inc. is a commercial-stage medical device company developing therapies for chronic neurological disorders through its proprietary neuromodulation technology. Its first product, the Evoke System, is designed to address chronic neuropathic pain. Founded in 2013, the company is headquartered in Bloomington, Minnesota.*Target Prices and Stop Loss levels
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Penny Stock Spotlight Report
A$399.00
Already a subscriber?
Sign in to read this report.
Required subscription
Penny Stock Spotlight Report
Explore emerging ASX penny stock opportunities through weekly research focused on early-stage companies, growth catalysts, and high-risk, high-potential investment ideas.
- ✓ Exclusive Weekly Penny Stock Research
- ✓ Delivered Every Monday
- ✓ Risk Rating: High Risk, High Reward
- ✓ Full Historical Report Access
A$399.00A$1500.00/ 12 months
Risk:High
Subscribe Now →
